Use of maintenance rituximab (R) in the United States following R-based induction for follicular lymphoma (FL). 18F-fluorodeoxglucose (FDG) positron emission tomography (PET) versus FLIPI as a ...

Therapeutic outcome in prognostic subgroups of de-novo acute myeloid leukemia (AML) and the role of the age factor. A study in 1834 patients of 16 to 84 years No significant financial relationships to ...

Please provide your email address to receive an email when new articles are posted on . Lymphopenia at diagnosis or during follow-up can predict OS among patients with multiple myeloma. Researchers ...

Please provide your email address to receive an email when new articles are posted on . Results showed two regimens — 120 mg/kg cyclophosphamide and 125 mg/m 2 fludarabine, or 60 mg/kg ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I am a female and almost 75 years old. My vital signs are ...

Severe lymphopenia, an adverse treatment effect associated with chemotherapy, radiotherapy, and immunotherapy, significantly lowers overall survival in non-small cell lung cancer and multiple types of ...

Progressive multifocal leukoencephalopathy (PML) occurring with ocrelizumab (Ocrevus) monotherapy developed in a 78-year-old man with progressive multiple sclerosis (MS), the first such case known, ...

Credit: X4 Pharmaceuticals. The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 4WHILM trial. Findings showed mavorixafor was associated with statistically ...